01694nas a2200229   4500008004100000245010900041210006900150260001800219300001000237490000600247520101500253653000901268653002001277653001001297653001801307653002301325653001701348100002101365700001701386700001701403856004401420       2021                        eng d00aBCG Induced Lymphadenitis: A Prerequisite in Parental Counseling during Pre and Post Vaccination Program0 aBCG Induced Lymphadenitis A Prerequisite in Parental Counseling   cDecember 2021  a49-500 v73 a<p class="rtejustify">Bacillus-Calmette-Guerin (BCG) is a live attenuated vaccine and used to prevent tuberculosis since 1921. BCG vaccination is performed as a part of expanded program of immunization (EPI). BCG vaccine is considered as a safe technique of tuberculosis prevention because there are only local adverse reactions seen with this and serious adverse reactions are rare. Lymphadenitis is the most frequent side effect of BCG vaccination. Intradermal BCG vaccination gives rise to erythromatous formation that consists of a cutaneous nodule at the site of injection and subclinical involvement of the regional lymph nodes, which is self limiting and requires no treatment. Lymphadenitis is the most frequent side effect of BCG vaccination. Fine needle aspiration is the quick, safe, and cost effective technique for diagnosis in addition to the management of BCG lymphadenitis. Here we report a case of 10- months’ healthy male patient with left axillary lymphadenitis post BCG vaccination.</p>
10aAEFI10aBCG vaccination10aFNAC.10aLymphadenitis10aPatient counseling10atuberculosis1 aSharma, Abhishek1 aBano, Gulnaz1 aMalik, Abdul  uhttp://jppcm.org/article/2021/7/3/49-5002191nas a2200241   4500008004100000245014500041210006900186260001700255300001000272490000600282520147800288653000801766653000901774653001301783653001601796653000901812653001501821653001101836653002001847100001701867700002101884856004401905       2020                        eng d00aUnapproved Combination Therapy of Doxycycline and Ivermectin in Covid-19 Pandemic, an Opportunistic Chance of Self-medication: A Case Report0 aUnapproved Combination Therapy of Doxycycline and Ivermectin in   cJanuary 2021  a69-710 v63 a<p class="rtejustify">To date, no standard drug therapy has proven effective to counter COVID-19 disease. There are only hit and trial based on assumptions and weak evidence that are directing prescribing practices for asymptomatic to symptomatic and serious cases of COVID-19. ICMR being the apex body, responsible for framing the guidelines for the management of disease in India has not yet approved the use of combination doxycycline and ivermectin in the prophylaxis or treatment of Covid-19 cases but being used in the treatment of COVID-19 infection. Their adverse drug reactions individually are well known among scientific community. Doxycycline ADRs range from gastrointestinal, urogenital, neuropsychiatric, respiratory, nervous system to skin and appendages. We have reported a case of doxycycline induced drug allergy (rashes) all over the trunk and legs as a result of self-medication. The event happened after a female patient had complaints of persistent fever and weakness consumed doxycycline and ivermectin on her friend’s advice and developed rashes on her trunk and legs. The above ADE is very mild but alarming for the medical fraternity that warrants strict compliance with the electronic/text/online prescription. The usage of doxycycline and ivermectin in the treatment of COVID-19 disease, as an indication of treatment should not be considered prior to any concrete evidence or issuance of treatment, guidelines by the apex body in India.</p>
10aADE10aADRs10aCOVID-1910aDoxycycline10aICMR10aIvermectin10aRashes10aSelf-medication1 aBano, Gulnaz1 aSharma, Abhishek  uhttp://jppcm.org/article/2020/6/4/69-71